Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides

Marc Swidergall1, Andreas M Ernst, Joachim F Ernst

  • 1Department Biologie, Molekulare Mykologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

Insights

Candida albicans Msb2* protein fragments bind and neutralize human antimicrobial peptides (AMPs) and the antibiotic daptomycin. This interaction protects fungi and bacteria, potentially compromising antibacterial therapies during coinfections.

Area of Science:

  • Microbiology
  • Immunology
  • Biochemistry

Background:

  • Candida albicans is a human fungal pathogen.
  • Antimicrobial peptides (AMPs) are crucial host defense molecules.
  • Fungal surface proteins can influence host-pathogen interactions.

Purpose of the Study:

  • To investigate the interaction between Candida albicans Msb2* glycofragment and antimicrobial peptides (AMPs).
  • To determine the role of Msb2* in protecting C. albicans and coinfecting bacteria from AMPs and antibiotics.
  • To assess the therapeutic implications of Msb2*-AMP interactions.

Main Methods:

  • Microscale thermophoresis was used to quantify Msb2*/LL-37 binding affinity.
  • Experiments involved O-glycosylation-deficient and denatured Msb2* variants.
  • Coculturing and mixed biofilm models were employed to study protection against daptomycin.

Main Results:

  • Msb2* high-affinity binding (KD = 73 nM) to LL-37 was demonstrated, dependent on O-glycosylation.
  • Msb2* also interacted with human defensins, protecting C. albicans.
  • Msb2* inactivated daptomycin, protecting Staphylococcus aureus, Enterococcus faecalis, and Corynebacterium pseudodiphtheriticum in coinfections.

Conclusions:

  • Shed Msb2* from Candida albicans binds and inactivates antimicrobial peptides and daptomycin.
  • This interaction compromises antibacterial therapy during coinfections.
  • Msb2* represents a potential target for improving antimicrobial efficacy.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...